We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LLYVA:NASDAQLiberty Live Holdings, Inc. - Series A Liberty Live Group Analysis

Data as of 2026-04-15 - not real-time

$98.23

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock is trading comfortably above its short‑ and long‑term moving averages, with a bullish MACD crossover and an RSI that sits in the upper half of its range, suggesting continued upward momentum. However, volume has been trending lower and 30‑day volatility remains elevated, indicating that price swings could be pronounced.
Fundamental backdrop: Revenue is expanding at a rapid clip, yet the company continues to generate negative operating and profit margins, and earnings per share remain in the red. The forward earnings multiple is substantially higher than the industry average, and the balance sheet is weighed down by a large debt load despite a recent debt‑exchange transaction aimed at refinancing. Market sentiment is currently in an “Extreme Greed” phase, which may be inflating the price beyond intrinsic value.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish technical indicators support near‑term price stability
  • Decreasing volume and high volatility raise short‑term uncertainty
  • Recent debt exchange may temporarily buoy market sentiment

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth offers upside potential if margins improve
  • Elevated forward P/E suggests price may be stretched
  • Debt burden remains a material concern pending further restructuring

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Fundamental weaknesses (negative earnings, high leverage) limit upside
  • Industry dynamics in live entertainment are cyclical and capital‑intensive
  • Current market enthusiasm may wane, aligning price closer to fundamentals

Key Metrics & Analysis

Financial Health

Revenue Growth29.00%
Profit Margin-22.77%
P/E Ratio52.8
ROA-1.86%
P/B Ratio-184.0
Op. Cash Flow$-29455000
Free Cash Flow$9.3M
Industry P/E18.9

Technical Analysis

TrendBullish
RSI59.4
Support$85.61
Resistance$99.82
MA 20$93.01
MA 50$91.73
MA 200$86.71
MACDBullish
VolumeDecreasing
Fear & Greed Index88.64

Valuation

Target Price$106.00
Upside/Downside7.91%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.94
Volatility40.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.